Can remote training for doctors improve diabetes care in community health centers?

NCT ID NCT07417865

First seen Feb 28, 2026 · Last updated Jun 23, 2026 · Updated 17 times

Summary

This study tests a tele-education program called ECHO Diabetes for primary care providers at 18 federally qualified health centers across the U.S. Providers attend twice-monthly online sessions for 6 months, led by a team at the University of Florida. The goal is to see if this training improves blood sugar control and increases use of diabetes technology like continuous glucose monitors and insulin pumps among their patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Alliance Chicago

    RECRUITING

    Chicago, Illinois, 60654, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Health Choice Network

    RECRUITING

    Miami, Florida, 33172, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

ECHO Diabetes tele-education program

What this could lead to

If successful, this could show that training primary care providers remotely helps improve blood sugar control and use of diabetes technology in underserved communities.

What could go wrong

This is a small, early-stage study with only 18 centers, so results may not apply broadly. It measures provider and center-level outcomes, not direct patient benefits.

Conditions

The condition(s) this trial relates to.

diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.